Therapeutic Targeting of the Myofibroblast in Fibrotic Lung Disease
$1,358,571P01FY2020HLNIH
Tulane University Of Louisiana, New Orleans LA
Investigators
Linked publications & trials
Paper 38713058Paper 37463440Paper 37423298Paper 37040483Paper 36928191Paper 36893326Paper 36848480Paper 36201669Paper 36043396Paper 35934931Paper 35675551Paper 34976199Paper 34528872Paper 34386777Paper 34117280Paper 34038004Paper 34028732Paper 33731433Paper 32657780Paper 32544088Paper 32446622Paper 31962055Paper 31953152Paper 31935199Paper 31928788Paper 31765873Paper 31172491Paper 30944258Paper 30903454Paper 30676324Paper 30626741Paper 30540232Paper 30321056Paper 30183330Paper 30130563Paper 30130138Paper 29986209Paper 29985427Paper 29967351Paper 29924937Paper 29671654Paper 29563175Paper 29524630Paper 29222329Paper 29192829Paper 29161077Paper 29019707Paper 28798256Paper 28756121Paper 28754682Paper 28450285Paper 28138565Paper 28049732Paper 28035849Paper 27979858Paper 27869174Paper 27859351Paper 27635790Paper 27560128Paper 27535718Paper 27394680Paper 27338106Paper 27233996Paper 27215501Paper 27196306Paper 27047952Paper 26884454Paper 26741177Paper 26729185Paper 26702150Paper 26658503Paper 26600197Paper 26575972Paper 26496488Paper 26432871Paper 26398012Paper 26318453Paper 26284610Paper 26231702Paper 26098211Paper 26072676Paper 26071551Paper 26026420Paper 25964487Paper 25835394Paper 25679265Paper 25658089Paper 25590812Paper 25451236Paper 25406319Paper 25365073Paper 25047515Paper 24835395Paper 24831009Paper 24726499Paper 24723426Paper 24718857Paper 24560583Paper 24265486Paper 24160862
View original record on NIH RePORTER →